Pharmacological effects of CDK4 & 6 selective inhibitor abemaciclib in hormone receptor-positive breast cancer

Chihiro Tamaki, Shin Ichi Hayashi, Aki Sato, Kaijiro Maeda, Sachi Sakaguchi, Sean Buchanan, Sotaro Enatsu

Research output: Contribution to journalReview articlepeer-review

Fingerprint Dive into the research topics of 'Pharmacological effects of CDK4 & 6 selective inhibitor abemaciclib in hormone receptor-positive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences